骨性肌少症与内在能力的交互作用及其与全因死亡率的关联:Toledo健康老龄化研究
该研究基于Toledo健康老龄化研究1142名老年人(75.1±6.0岁,53.1%为女性),横断面分析骨性肌少症与内在能力(IC)的关联,并前瞻性分析全因死亡率。结果显示,骨性肌少症患者总IC得分更低(76.6±1.1分),且在运动、认知、活力、感觉域表现更差;中位随访6.2年中,骨性肌少症合并低IC者死亡风险升高(HR=2.55,95%CI 1.31-4.96,p=.004)。
要点
- 骨性肌少症与更低的总IC得分及多个IC域受损相关。
- 骨性肌少症合并低IC的老年人全因死亡风险升高(HR=2.55)。
- 单纯骨量减少/骨质疏松未显示与死亡风险的独立关联。
核心结论
- 骨性肌少症与更低的总IC及多数IC域受损相关,且骨性肌少症合并低IC与全因死亡风险升高相关。
研究设计与样本
- Toledo健康老龄化研究的横断面IC分析与前瞻性全因死亡率分析,共纳入1142名参与者(75.1±6.0岁,53.1%为女性)。
- 参与者按DXA及EWGSOP2标准分为无肌肉骨骼疾病、骨量减少/骨质疏松、肌少症、骨性肌少症四组。
- IC以整合运动、认知、心理、活力与感觉域的综合评分进行操作性定义。
主要发现
- 骨性肌少症者总IC为76.6±1.1分,低于无肌肉骨骼疾病者83.7±0.5分(p<.001)及骨量减少/骨质疏松者81.3±0.3分(p<.001),后两组间差异亦有统计学意义(p<.001)。
- 骨性肌少症与运动、认知、活力、感觉域较差结果相关(均p<.01),心理域无显著关联。
- 中位随访6.2年,骨性肌少症(而非骨量减少/骨质疏松)与较高死亡风险相关[HR(95%CI)=1.96(1.02-3.77);p=.045]。
- 按IC中位数分为高/低后联合分析,该关联仅见于骨性肌少症合并低IC者[HR=2.55(1.31-4.96);p=.004]。
关键数值与推荐
- 骨性肌少症定义依据DXA及EWGSOP2标准。
- IC综合评分整合运动、认知、心理、活力、感觉五个域。
- 骨性肌少症合并低IC者死亡风险HR=2.55(95%CI 1.31-4.96;p=.004)。
临床怎么用
- 对老年人可同时评估骨性肌少症与IC,识别骨性肌少症合并低IC的高死亡风险人群。
- IC评估可涵盖运动、认知、活力、感觉等域,以发现骨性肌少症患者的多域受损。
局限性
- 原文摘要未报告局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteosarcopenia-the coexistence of osteopenia/osteoporosis and sarcopenia-is associated with numerous adverse health outcomes, but its association with intrinsic capacity (IC) remains unknown. We aimed to explore the associations of osteosarcopenia with IC and all-cause mortality in older adults. METHODS: We conducted a cross-sectional analysis of IC and a prospective analysis of all-cause mortality in 1142 participants from the Toledo Study for Healthy Aging (75.1 ± 6.0 years, 53.1% women). Participants were classified as having no musculoskeletal disorders, osteopenia/osteoporosis, sarcopenia, or osteosarcopenia (DXA- and EWGSOP2-based criteria). IC was operationalized as a composite score integrating locomotion, cognition, psychological, vitality, and sensory domains. RESULTS: Older adults with osteosarcopenia exhibited lower total IC (76.6 ± 1.1 points) than those without musculoskeletal disorders (83.7 ± 0.5 points; p < .001) or with osteopenia/osteoporosis (81.3 ± 0.3 points; p < .001), with significant differences also found between the latter groups (p < .001). Specifically, osteosarcopenia was associated with poorer results in the locomotion, cognition, vitality, and sensory domains (all p < .01), but not in the psychological domain. Over a median 6.2-year follow-up, osteosarcopenia-but not osteopenia/osteoporosis-was associated with a higher risk of mortality compared to those without musculoskeletal disorders [HR (95% CI)=1.96 (1.02-3.77); p = .045]. In joint analyses with IC status (high vs low, segregated by the median), this association was specifically observed among participants with osteosarcopenia and low IC [HR = 2.55 (1.31-4.96); p = .004]. CONCLUSIONS: Osteosarcopenia is associated with lower total IC and impairments across most IC domains. This finding is of clinical relevance, as the combination of this condition and low IC is associated with an increased mortality risk.
引用
- Baltasar-Fernandez I, Valenzuela PL, Rodríguez-Gómez I, et al. The interplay between osteosarcopenia and intrinsic capacity: insights and associations with all-cause mortality in the Toledo Study for Healthy Aging. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41955333. doi:10.1093/gerona/glag090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。